NO20055948L - Rensing av HER-2 varianter - Google Patents

Rensing av HER-2 varianter

Info

Publication number
NO20055948L
NO20055948L NO20055948A NO20055948A NO20055948L NO 20055948 L NO20055948 L NO 20055948L NO 20055948 A NO20055948 A NO 20055948A NO 20055948 A NO20055948 A NO 20055948A NO 20055948 L NO20055948 L NO 20055948L
Authority
NO
Norway
Prior art keywords
provides
chromatography
variant
purification
variants
Prior art date
Application number
NO20055948A
Other languages
English (en)
Inventor
Klaus Gregorius Nielsen
Marie Eskling
Original Assignee
Pharmexa As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmexa As filed Critical Pharmexa As
Publication of NO20055948L publication Critical patent/NO20055948L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103Receptors for growth factors
    • A61K39/001106Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)

Abstract

Foreliggende oppfinnelse skaffer til veie en ny metode for rensing av EGFR famihe proteiner oppnådd fra kulturer av insektceller. Fremgangsmåten omfatter følgende trinn med a) diafiltrering og utbytting av dyrkningsmediet med buffer, b) immobilisert metall affinitet kromatografi (IMAC), c) størrelse eksklusjons kromatografi (SEC), og d) anionbytter kromatografi (AIE). Fremgangsmåten skaffer også til veie en immunogen variant av HER-2 proteinet for hvilken renseprosessen har vært særlig tilpasset, så vel som måter for fremstilling av varianten.
NO20055948A 2003-06-25 2005-12-14 Rensing av HER-2 varianter NO20055948L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48231503P 2003-06-25 2003-06-25
DKPA200300954 2003-06-25
PCT/DK2004/000451 WO2004113377A1 (en) 2003-06-25 2004-06-24 Purification of her-2 variants

Publications (1)

Publication Number Publication Date
NO20055948L true NO20055948L (no) 2005-12-14

Family

ID=33542436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055948A NO20055948L (no) 2003-06-25 2005-12-14 Rensing av HER-2 varianter

Country Status (12)

Country Link
EP (2) EP1641819B1 (no)
JP (1) JP4579912B2 (no)
AT (1) ATE429447T1 (no)
AU (1) AU2004249362B2 (no)
CA (1) CA2530233C (no)
DE (1) DE602004020769D1 (no)
DK (1) DK1641819T3 (no)
ES (1) ES2325584T3 (no)
MX (1) MXPA05013389A (no)
NO (1) NO20055948L (no)
NZ (1) NZ544017A (no)
WO (1) WO2004113377A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060033870A (ko) 2003-06-25 2006-04-20 파멕사 에이/에스 Her-2 변이체의 정제
WO2006102901A2 (en) * 2005-03-31 2006-10-05 Pharmexa A/S Immunogenic egfr peptides comprising foreign t cell stimulating epitope
EP2073837B1 (en) * 2006-10-06 2014-06-25 Bavarian Nordic Inc. Recombinant modified vaccinia ankara virus encoding a her-2 antigen in combination with a taxane for use in treating cancer
EP4211468A4 (en) * 2020-09-11 2024-10-09 Glympse Bio Inc DETECTION OF EX VIVO PROTEASE ACTIVITY FOR DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT OF DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
JP2002526419A (ja) 1998-10-05 2002-08-20 ファーメクサ エイ/エス 治療上のワクチン注射のための新規な方法
CN1201004C (zh) * 1999-01-29 2005-05-11 考丽克萨有限公司 HER-2/neu融合蛋白
WO2003087338A2 (en) * 2002-04-11 2003-10-23 Amgen, Inc. Her-2 receptor tyrosine kinase molecules and uses thereof

Also Published As

Publication number Publication date
JP2007523615A (ja) 2007-08-23
CA2530233A1 (en) 2004-12-29
EP1641819B1 (en) 2009-04-22
DK1641819T3 (da) 2009-08-03
NZ544017A (en) 2008-04-30
JP4579912B2 (ja) 2010-11-10
MXPA05013389A (es) 2006-03-17
EP1641819A1 (en) 2006-04-05
ATE429447T1 (de) 2009-05-15
EP2090586A1 (en) 2009-08-19
AU2004249362B2 (en) 2011-08-25
CA2530233C (en) 2012-09-11
AU2004249362A1 (en) 2004-12-29
WO2004113377A1 (en) 2004-12-29
DE602004020769D1 (de) 2009-06-04
ES2325584T3 (es) 2009-09-09

Similar Documents

Publication Publication Date Title
NO20063478L (no) Noytraliserende epitopebasert vekstfremmende vaksine
EP1568710A3 (en) Antibody purification method
WO2008013454A3 (en) Immunogenic compounds and protein mimics
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
NO20071432L (no) Fremgangsmate for konsentrasjon av antistoffer of terapeutiske produkter derav.
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
WO2005016968A3 (en) Reducing protein a leaching during protein a affinity chromatography
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
WO2003062375A3 (en) Stabilizing polypeptides which have been exposed to urea
ATE521627T1 (de) Identifikation kreuzreaktiver epitope des flavivirus-hüllglykoproteins
MX2009012451A (es) Plantas con rasgos mejorados relacionados con el rendimiento y un metodo para producirlas.
IL176522A0 (en) Universal amplification of fragmented rna
NO20063278L (no) Hurtigfremstilling av nukleinsyrer ved enzymatisk fordoyelse
WO2007130535A3 (en) Novel protein fusion/tag technology
AR048651A1 (es) Proceso de amonolisis enzimatica para preparacion de compuestos intermediarios para inhibidores de dipeptidilo peptidasa iv
NO20055948L (no) Rensing av HER-2 varianter
NO20075911L (no) Genetisk modifisert mikroorganisme og fremgangsmate for fremstilling av makrolidforbindelser ved anvendelse av mikroorganismen
EA200600102A1 (ru) Очистка вариантов her-2
ATE386823T1 (de) Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung
TW200722435A (en) Purification of proteins with cationic surfactant
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer
DE50002865D1 (de) Verfahren zur herstellung von benzofuranonoximen
WO2003064597A3 (en) Aggrecanase molecules
ATE381576T1 (de) Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application